Hints and tips:
...Auden Mckenzie and Actavis UK increased the price of a 10mg packet by more than 10,000 per cent compared with the original branded version of the drug, the CMA said....
...Auden McKenzie hiked prices by over 10,000 per cent and paid off would-be competitors, a practice continued by Actavis UK when it took over sales of the tablets in 2015, the regulator said....
AbbVie’s planned $63bn purchase of the Botox-maker will earn $123m for bank
David Tepper’s Appaloosa hedge fund had been instigating for change
...It was once a Wall Street darling, executing an inversion deal with Actavis and other aggressive acquisitions. As its growth prospects slowed, investors grew restless....
...A former Bausch & Lomb executive, the 49-year-old built Allergan through a succession of deals that began in 2013 when the company he ran, then called Actavis, bought Ireland-headquartered Warner Chilcott...
...The firm’s original investment in Allergan was a money-spinner, reaping gains of $2.3bn before the company agreed a sale to Actavis....
...Actavis Holdco U.S., Inc.; Actavis Pharma, Inc.; Ascend Laboratories, LLC; Apotex Corp.; Dr....
...Actavis to keep prices artificially high....
...The CMA also alleges that Actavis UK abused its dominant position by inducing Concordia to delay its independent entry into the market....
...It is the second time in recent months that the CMA has said it would investigate Actavis over pricing....
...Allergan received a 10 per cent stake, or 100m shares, in Teva last year after it agreed to sell its generics business Actavis to the Israeli drugmaker last year....
...However, the CMA said that “by charging excessive and unfair pricing” Actavis had broken competition law....
...The relevant SEC filings were made by Allergan, Inc. prior to its acquisition by Actavis plc....
...Actavis was sold last year by Allergan of the US to Israel’s Teva for $40.5bn....
...The group has ongoing patent disputes with Mylan, Actavis, Par, Sandoz, Alvogen and Rhodes Pharmaceuticals, all of which are attempting to launch their own opioid addiction treatments....
...The court also gave a partial victory to drugmakers Actavis and Par Pharmaceutical, which had lost a patent battle with Indivior....
...Teva, the Israeli maker of generic drugs, bought Actavis Generics from the US’s Allergan for $40.5bn....
...US drugmaker Pfizer plans to continue a legal battle with rival Actavis over the way its blockbuster drug Lyrica is sold in the UK after the Court of Appeal on Thursday rejected a claim of patent infringement...
...It is also facing an appeal in a patent battle against Actavis and Par Pharmaceutical....
...Less than a year later Forest was acquired by Actavis (which subsequently merged with Allergan) resulting in massive gains for Forest shareholders....
...In 2013 Ireland-based Warner Chilcott bought US-based Actavis, then in 2015, Actavis bought US-based Allergan....
...Actavis acquired Allergan, which makes the Botox cosmetic, last year and adopted its name after the deal closed....
...Allergan, previously known as Actavis, was itself one of numerous lesser-known US companies to have “redomiciled” to Ireland or other lower-tax countries....
International Edition